Pratt Community Health Clinic, Llc Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 206 S Main St, Pratt, KS 67124 Phone: 620-388-7741 |
Pratt Internal Medicine Group Pa Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 420 Country Club Rd, Pratt, KS 67124 Phone: 620-672-7415 Fax: 620-672-7414 |
Pratt Family Practice Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 203 Watson St, Suite 200, Pratt, KS 67124 Phone: 620-672-7422 Fax: 620-450-1601 |
Pratt Family Practice Family Medicine Medicare: Medicare Enrolled Practice Location: 203 Watson St, Suite 200, Pratt, KS 67124 Phone: 620-672-7422 Fax: 620-508-6476 |
South Central Bone & Joint Center Clinic/Center - Multi-Specialty Medicare: Medicare Enrolled Practice Location: 203 Watson St, Suite 300, Pratt, KS 67124 Phone: 620-672-1002 Fax: 620-672-7268 |
Pratt Internal Medicine Group Clinic/Center - Rural Health Medicare: Medicare Enrolled Practice Location: 420 Country Club Rd, Pratt, KS 67124 Phone: 620-672-7415 |
News Archive
Research at Michigan State University found that a new test that provides a new, quicker method for determining the presence of a type of strep that can cause fatal meningitis or pneumonia in newborns is effective more than 90 percent of the time.
People with dementia exhibit many far-reaching changes of conduct. Embarrassment, fear, and reduced orientation ability decrease their degree of independence and social inclusion. The QuartrBack project coordinated by the Evangelische Heimstiftung now combines volunteer work with technologies for location, monitoring, information, and professional care.
A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
Research has shown that procaine and procaine-hydrochloride can reduce replication of SARS-CoV-2 and influenza A viruses in infected cells and reduce the production of cytokines by the viruses, making them potentially useful for treating COVID-19.
Vaccines currently being developed against two types of virus that cause cervical cancer - HPV16 or HPV18 - may prevent a larger proportion of high-risk HPV infections in Europe than sub-Saharan Africa, suggests a study being published online by The Lancet.
› Verified 1 days ago